KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Short term Debt (2016 - 2025)

Historic Short term Debt for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $3.8 billion.

  • Thermo Fisher Scientific's Short term Debt fell 711.86% to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 711.86%. This contributed to the annual value of $2.2 billion for FY2024, which is 3865.34% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Short term Debt of $3.8 billion as of Q3 2025, which was down 711.86% from $2.2 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Short term Debt registered a high of $6.1 billion during Q2 2023, and its lowest value of $4.0 million during Q2 2021.
  • In the last 5 years, Thermo Fisher Scientific's Short term Debt had a median value of $2.8 billion in 2025 and averaged $3.0 billion.
  • In the last 5 years, Thermo Fisher Scientific's Short term Debt crashed by 9945.8% in 2021 and then skyrocketed by 4655000.0% in 2022.
  • Over the past 5 years, Thermo Fisher Scientific's Short term Debt (Quarter) stood at $2.5 billion in 2021, then skyrocketed by 119.91% to $5.6 billion in 2022, then tumbled by 35.31% to $3.6 billion in 2023, then tumbled by 38.65% to $2.2 billion in 2024, then skyrocketed by 72.67% to $3.8 billion in 2025.
  • Its last three reported values are $3.8 billion in Q3 2025, $2.2 billion for Q2 2025, and $2.8 billion during Q1 2025.